These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
389 related items for PubMed ID: 1833051
1. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Gong Y, Anzai Y, Murphy LC, Ballejo G, Holinka CF, Gurpide E, Murphy LJ. Cancer Res; 1991 Oct 15; 51(20):5476-81. PubMed ID: 1833051 [Abstract] [Full Text] [Related]
2. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells. Murphy LC, Dotzlaw H, Wong MS, Miller T, Murphy LJ. Cancer Res; 1991 Apr 15; 51(8):2051-7. PubMed ID: 1849041 [Abstract] [Full Text] [Related]
3. Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. Murphy LJ, Gong Y, Murphy LC. J Steroid Biochem Mol Biol; 1992 Mar 15; 41(3-8):309-14. PubMed ID: 1532902 [Abstract] [Full Text] [Related]
8. Effects of cytokines on epidermal growth factor receptor expression by malignant trophoblast cells in vitro. Steller MA, Mok SC, Yeh J, Fulop V, Anderson DJ, Berkowitz RS. J Reprod Med; 1994 Mar 15; 39(3):209-16. PubMed ID: 8035376 [Abstract] [Full Text] [Related]
9. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma. Ripley D, Tang XM, Ma C, Chegini N. Gynecol Oncol; 2001 May 15; 81(2):301-9. PubMed ID: 11330966 [Abstract] [Full Text] [Related]
10. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Seth D, Shaw K, Jazayeri J, Leedman PJ. Br J Cancer; 1999 May 15; 80(5-6):657-69. PubMed ID: 10360641 [Abstract] [Full Text] [Related]
11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H. Cell Growth Differ; 1990 Sep 15; 1(9):407-20. PubMed ID: 1981145 [Abstract] [Full Text] [Related]
13. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro. Morishige K, Kurachi H, Amemiya K, Adachi H, Inoue M, Miyake A, Tanizawa O, Sakoyama Y. Cancer Res; 1991 Nov 01; 51(21):5951-5. PubMed ID: 1718591 [Abstract] [Full Text] [Related]
14. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y, Ballejo G, Murphy LC, Murphy LJ. Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100 [Abstract] [Full Text] [Related]
15. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z, Masui H, Altas I, Mendelsohn J. Cancer Res; 1993 Sep 15; 53(18):4322-8. PubMed ID: 8364927 [Abstract] [Full Text] [Related]
16. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha. Rodeck U, Williams N, Murthy U, Herlyn M. J Cell Biochem; 1990 Oct 15; 44(2):69-79. PubMed ID: 2250044 [Abstract] [Full Text] [Related]
17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y. Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583 [Abstract] [Full Text] [Related]
18. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium. Mirkin S, Archer DF. Maturitas; 2007 Aug 20; 57(4):338-46. PubMed ID: 17478063 [Abstract] [Full Text] [Related]
19. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV. Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237 [Abstract] [Full Text] [Related]
20. Expression and regulation of retinoic acid receptors in human breast cancer cells. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL. Cancer Res; 1992 Apr 15; 52(8):2236-42. PubMed ID: 1313739 [Abstract] [Full Text] [Related] Page: [Next] [New Search]